Frank A Damelio Net Worth

The estimated Net Worth of Frank A Damelio is at least 33.3 百万$ dollars as of 10 April 2024. Frank Damelio owns over 17,389 units of Zoetis Inc stock worth over 3,303,736$ and over the last 21 years Frank sold ZTS stock worth over 30,031,571$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Frank Damelio ZTS stock SEC Form 4 insiders trading

Frank has made over 36 trades of the Zoetis Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Frank exercised 17,389 units of ZTS stock worth 3,303,736$ on 10 April 2024.

The largest trade Frank's ever made was exercising 324,932 units of Zoetis Inc stock on 26 February 2014 worth over 4,126,636$. On average, Frank trades about 31,044 units every 42 days since 2004. As of 10 April 2024 Frank still owns at least 17,389 units of Zoetis Inc stock.

You can see the complete history of Frank Damelio stock trades at the bottom of the page.

What's Frank Damelio's mailing address?

Frank's mailing address filed with the SEC is C/O HEWLETT PACKARD ENTERPRISE COMPANY, 1701 E. MOSSY OAKS ROAD, SPRING, TX, 77389.

Insiders trading at Zoetis Inc

Over the last 12 years, insiders at Zoetis Inc have traded over 876,669,659$ worth of Zoetis Inc stock and bought 1,602,140 units worth 77,083,975$ . The most active insiders traders include Square Capital Management, ...、Frank A Damelio、Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of 14,414,921$. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth 170,041$.

What does Zoetis Inc do?

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.

Complete history of Frank Damelio stock trades at Catalent、Hewlett Packard Enterprise Co、Humana、Pfizer、Zoetis Inc

Zoetis Inc executives and stock owners

Zoetis Inc executives and other stock owners filed with the SEC include:

• Glenn David,
  Chief Financial Officer, Executive Vice President
• Kristin Peck,
  Chief Executive Officer, Director
• Catherine Knupp,
  Executive Vice President, President - Research and Development
• Kristin C. Peck,
  CEO & Director
• Wafaa Mamilli,
  Exec. VP and Chief Information & Digital Officer
• Roman Trawicki,
  Exec. VP and Pres of Global Manufacturing & Supply
• Glenn C. David,
  Exec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance
• Michael McCallister,
  Non-Executive Independent Chairman of the Board
• Robert Scully,
  Independent Director
• Gregory Norden,
  Independent Director
• Paul Bisaro,
  Independent Director
• William Steere,
  Independent Director
• Linda Rhodes,
  Independent Director
• Willie Reed,
  Independent Director
• Louise Parent,
  Independent Director
• Sanjay Khosla,
  Independent Director
• Frank D'Amelio,
  Independent Director
• Roman Trawicki,
  Executive Vice President, President - Global Manufacturing and Supply
• Heidi Chen,
  Executive Vice President, General Counsel, Corporate Secretary
• Roxanne Lagano,
  Chief Human Resource Officer, Executive Vice President and Global Operations
• Heidi C. Chen,
  Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics
• Roxanne Lagano,
  Exec. VP and Chief HR Officer & Global Operations
• Wetteny N. Joseph,
  Exec. VP & CFO
• Timothy J. Bettington,
  Exec. VP and Pres of U.S. Operations & Global Customer Experience
• William Price,
  VP & Chief Communications Officer
• Steven Frank,
  VP of Investor Relations
• Gavin Hattersley,
  Director
• Robert Edward Kelly,
  Executive Vice President
• Alejandro Bernal,
  Executive Vice President
• Juan Ramon Alaix,
  Director
• Clinton A. Jr. Lewis,
  Executive Vice President
• Sherry N Pudloski,
  Executive Vice President
• Robert J Polzer,
  Executive Vice President
• Amy W Schulman,
  Director
• Sandra J. Beaty,
  Executive Vice President
• Joyce J. Lee,
  Executive Vice President
• Douglas E. Giordano,
  Director
• William F Doyle,
  
• Inc Pfizer,
  Director
• Square Capital Management, ...,
  
• Stefan Weiskopf,
  Executive Vice President
• Richard A. Passov,
  EVP, Chief Financial Officer
• Paul Herendeen,
  Exec. V.P. and CFO
• Charles H Hill,
  Director
• Geno J Germano,
  Director
• Andrew Fenton,
  Executive Vice President
• James Michael Mc Farland,
  Executive Vice President
• Wafaa Mamilli,
  Executive Vice President
• Timothy J Bettington,
  Executive Vice President
• Antoinette Renee Leatherberry,
  Director
• Astorga Jeannette Ferran,
  Executive Vice President
• Abhay U Nayak,
  Executive Vice President
• Wetteny Joseph,
  Chief Financial Officer
• Rimma Driscoll,
  Executive Vice President
• Vanessa Broadhurst,
  Director
• Jamie Brannan,
  Executive Vice President
• Nicholas Ashton,
  Executive Vice President
• Soria Ester Banque,
  Executive Vice President